To date, very little is known about the effects of direct oral anticoagulants (DOA) use in patients with cervical artery dissection (CAD) and cerebral venous thrombosis (CVT). We present our initial experience with the use of DOA for CAD and CVT and an overview of the published literature.

Direct oral anticoagulants in patients with cervical artery dissection and cerebral venous thrombosis. A case series and review of the literature

Cappellari, Manuel;
2017

Abstract

To date, very little is known about the effects of direct oral anticoagulants (DOA) use in patients with cervical artery dissection (CAD) and cerebral venous thrombosis (CVT). We present our initial experience with the use of DOA for CAD and CVT and an overview of the published literature.
Cerebral venous thrombosis; Cervical artery dissection; Direct oral anticoagulants; New oral anticoagulants; Non-vitamin K anticoagulants; Administration, Oral; Adult; Aneurysm, Dissecting; Anticoagulants; Female; Humans; Intracranial Aneurysm; Intracranial Thrombosis; Male; Middle Aged; Retrospective Studies; Stroke; Treatment Outcome; Venous Thrombosis
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11562/979819
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact